Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that Tuomo Pätsi has been appointed President of the Europe, Middle East and Africa (EMEA) region for the company. In this role, he will oversee the current portfolio in EMEA as well as international efforts related to the company’s broad pipeline of clinical programs in areas including immunotherapy, epigenetics, ubiquitin ligase targets, cancer metabolism and others. Mr. Pätsi takes over from Alan Colowick, MD, who has led Celgene in the region since 2012 and who returns to the United States, taking on another senior strategic position for the company.
Help employers find you! Check out all the jobs and post your resume.
